{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:48:29Z","timestamp":1649191709513},"reference-count":20,"publisher":"Kurume Medical Journal","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2018,12,31]]},"DOI":"10.2739\/kurumemedj.ms654003","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T17:04:02Z","timestamp":1573578242000},"page":"185-191","source":"Crossref","is-referenced-by-count":0,"title":["Steroid Resistant Hypereosinophilic Syndrome Suspected to Be Caused by Aberrant T-cell Subset"],"prefix":"10.2739","volume":"65","author":[{"given":"NORIHIRO","family":"NAGAMURA","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Allergy, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NORIKO","family":"FUKIWAKE","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RYOTARO","family":"OZASA","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Shimane Prefectural Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1445","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Helbig G, Wieczorkiewicz A, Dziaczkowska-Suszek J, Majewski M, and Kyrcz-Krzemien S. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Hematol J 2009; 94:1236-1241.","DOI":"10.3324\/haematol.2008.005447"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Brito-Babapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 2003; 121:203-223.","DOI":"10.1046\/j.1365-2141.2003.04195.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Roufosse FE, Goldman M, and Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis 2007; 2:37.","DOI":"10.1186\/1750-1172-2-37"},{"key":"4","unstructured":"4. Yamada Y, Rothenberq ME, and Cancelas JA. Current concept on the pathogenesis of the hypereosinophilic syndrome\/ chronic eosinophilic leukemia. Transl Oncogenomics 2006; 1:53-63."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tefferi A, Gotlib J, and Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 2010; 85:58-164.","DOI":"10.4065\/mcp.2009.0503"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Simon HU and Klion A. Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol 2012; 49:160-170.","DOI":"10.1053\/j.seminhematol.2012.01.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Roufosse F, Cogan E, and Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 2004; 59:673-689.","DOI":"10.1111\/j.1398-9995.2004.00465.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Helbig G, Wichary R, Razny M, Rodzaj M, Wozniczka K et al. The proportion of CD3-CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES). Scand J Immunol 2010; 72:372-373.","DOI":"10.1111\/j.1365-3083.2010.02436.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gotlib J. World Health Organization-defined eosinophilic disorders:2017 update on diagnosis, risk stratification, and management. Am J Hematol 2017; 92:1243-1259.","DOI":"10.1002\/ajh.24880"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lef\u00e8vre G, Copin MC, Staumont-Sall\u00e9 D, Avenel-Audran M, Aubert H et al. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore) 2014; 93:255-266.","DOI":"10.1097\/MD.0000000000000088"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Roufosse F, Cogan E, and Goldman M. Lymphocytic variant hypereosinophilic syndrome. Immunol Allergy Clin North Am 2007; 27:389-413.","DOI":"10.1016\/j.iac.2007.07.002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee RW, Creed TJ, Schewitz LP, Newcomb PV, Nicholson LB et al. CD4+ CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids. J Immunol 2007; 179:7941-7948.","DOI":"10.4049\/jimmunol.179.11.7941"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tabata R, Tabata C, Katashima Y, and Yasumizu R. Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome. Int Immunopharmacol 2013; 16:488-491.","DOI":"10.1016\/j.intimp.2013.04.033"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maillefert JF, Duchamp O, Solary E, Genne P, and Tavernier C. Effects of cyclosporine at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells. Ann Rheum Dis 2000; 59:146-148.","DOI":"10.1136\/ard.59.2.146"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Roufosse F, de Lavareille A, Schanden\u00e9 L, Cogan E, Georgelas A et al. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol 2010; 126:828-835.","DOI":"10.1016\/j.jaci.2010.06.049"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yoon TY, Ahn GB, and Chang SH. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review. J Dermatol 2000; 27:110-115.","DOI":"10.1111\/j.1346-8138.2000.tb02131.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Roufosse F. Management of Hypereosinophilic Syndromes. Immunol Allergy Clin North Am 2015; 35:561-575.","DOI":"10.1016\/j.iac.2015.05.006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kemph W, Kazakov DV, Szep Z, and Vanecek T. CD30 clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome. J Cutan Pathol 2015; 42:130-135.","DOI":"10.1111\/cup.12454"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Granel B, Serratrice J, Swiader L, Horshowski N, Blaise D et al. Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma. Cancer 2000; 89:2138-2143.","DOI":"10.1002\/1097-0142(20001115)89:10<2138::AID-CNCR15>3.0.CO;2-W"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. d\u2019El\u00e9e JM, Parrens M, Merci\u00e9 P, Longy Boursier M, Dieval C et al. Hypereosinophilic syndrome-lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestation. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116:185-190.","DOI":"10.1016\/j.oooo.2013.03.017"}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/65\/4\/65_MS654003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T23:12:24Z","timestamp":1579907544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/65\/4\/65_MS654003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms654003","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}